Donanemab and lecanemab have been shown to delay progression from mild to moderate Alzheimer's by up to six months but are ...

False diagnoses are used to mask inappropriate use of antipsychotic drugs on patients with dementia, a practice called chemical restraint, a government watchdog report said.

Professor Fiona Carragher, chief policy and research officer at Alzheimer’s Society, said: “Rapid advancements in AI will give people affected by early-stage dementia the opportunity to stay safely in ...

USC is getting ready to accept patients to its new Brain Health Center, where high-powered MRI scanners will help doctors and researchers better understand and diagnose disease like Alzheimer's.

The groups are calling for genotype-informed prevention and treatment strategies, APOE stratification in clinical trials, and related public policies.

The analysis found that physician performance varied widely across U.S. states, with Alaska the poorest-performing state, where 80% of doctors failed to screen dementia patients a ...

Adults with diabetes had an elevated risk for dementia, with a higher risk among those with type 1 compared with type 2 ...

The need for neurological care is especially acute in South Carolina, which has struggled to deliver timely, top-notch brain ...

Smith Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory ...

Now, with the passing of House Bill 565, also known as Jill’s Law, all Mississippians will have access to biomarker testing ...

A new Duke study is exploring whether cells inside the nose could reveal early signs of Alzheimer’s disease. Researchers say ...

HHS Secretary Robert F. Kennedy Jr. appointed Michelle Branham as chair of the federal Advisory Council on Alzheimer’s ...